Part 2 of 4: Recruitment may bring people into sterile processing. Development is what determines whether they stay.
|Articles|June 12, 2020
- Infection Control Today, June 2020 (Vol. 24 No. 5)
- Volume 24
- Issue 5
Bug of the Month: You Don’t Want COVID-19 Following in My Footsteps
Bug of the Month helps educate readers about existing and emerging pathogens of clinical importance in healthcare facilities today.
Advertisement
Bug of the Month helps educate readers about existing and emerging pathogens of clinical importance in healthcare facilities today. Each column explores the Bug of the Month's etiology, the infections it can cause, the modes of transmission, and ways to fight its spread. The pathogen profiles will span bacterial, viral, fungal and parasitic species. We encourage you to use Bug of the Month as a teaching tool to help educate healthcare personnel and start a dialogue about microbiology-related imperatives.
Articles in this issue
over 6 years ago
Telehealth in the Time of COVID-19: A 20-Year Overnight Successover 6 years ago
What the COVID-19 Pandemic Teaches Infection Preventionistsover 6 years ago
Cloth Masks Are Useless Against COVID-19Advertisement
Related to this article
At IDWeek 2026, Rachel Sidebottom discusses research exploring phage-antibiotic combinations, the potential for predictive modeling, and an investigation identifying an ST5 strain of nontoxigenic Corynebacterium diphtheriae circulating in Albuquerque.
Finding infections earlier is only part of the work. At IDWeek 2026, David Weber, MD, MPH, explored how broader surveillance and emerging technologies could help infection preventionists spend more time supporting safer care.
Two experts give an update ahead of the first season with a new mRNA vaccine against flu.
Part 1 of 4: How emerging sterile processing leaders are redefining leadership through trust, accountability, psychological safety, and professional development.
This week in infection prevention: Kenya’s Bundibugyo virus response shows why execution, not just planning, determines outcomes, and France reported the first known human Shamonda virus infection. Our roundup also covers brucellosis, blood donor screening, and long-acting HIV antibody findings from IDWeek 2026.
At IDWeek 2026, Jimmy Chang, PhD, discussed investigational HIV antibodies TMB-365 and TMB-380, explaining their complementary mechanisms, early study findings, and ongoing evaluation as a long-acting maintenance regimen.
At IDWeek 2026, Samuel Ntow, MBChB, MPH, discussed research findings of reactive infection screening markers in 18.3% of replacement donor records from rural Ghana, highlighting opportunities for further evaluation and linkage to care.
Advertisement
Advertisement
Trending on Infection Control Today
1
The Next Generation of SPD Leadership: People First, Standards Always
2
Early Flu, Late RSV: What Infection Preventionists Should Watch This Respiratory Season
3
The Next Generation of SPD Leadership: Building the Workforce of the Future
4
IDWeek 2026: Phage-Antibiotic Research and Nontoxigenic C diphtheriae in Albuquerque
5